<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33479240</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>SVIP is a molecular determinant of lysosomal dynamic stability, neurodegeneration and lifespan.</ArticleTitle><Pagination><StartPage>513</StartPage><MedlinePgn>513</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">513</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-20796-8</ELocationID><Abstract><AbstractText>Missense mutations in Valosin-Containing Protein (VCP)&#xa0;are linked to diverse degenerative diseases including IBMPFD, amyotrophic lateral sclerosis (ALS), muscular dystrophy and Parkinson's disease. Here, we characterize a VCP-binding co-factor (SVIP) that specifically recruits VCP to lysosomes. SVIP is essential for lysosomal dynamic stability and autophagosomal-lysosomal fusion. SVIP mutations cause muscle wasting and neuromuscular degeneration while muscle-specific SVIP over-expression increases lysosomal abundance and is sufficient to extend lifespan in a context, stress-dependent manner. We also establish multiple links between SVIP and VCP-dependent disease in our Drosophila model system. A biochemical screen identifies a disease-causing VCP mutation that prevents SVIP binding. Conversely, over-expression of an SVIP mutation that prevents VCP binding is deleterious. Finally, we identify a human SVIP mutation and confirm the pathogenicity of this mutation in our Drosophila model. We propose a model for VCP disease based on the differential, co-factor-dependent recruitment of VCP to intracellular organelles.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Alyssa E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orr</LastName><ForeName>Brian O</ForeName><Initials>BO</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fetter</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-1558-100X</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moughamian</LastName><ForeName>Armen J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Primeaux</LastName><ForeName>Logan A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geier</LastName><ForeName>Ethan G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Louisiana State University, Baton Rouge, LA, 70803, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Jennifer S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Bruce L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Graeme W</ForeName><Initials>GW</Initials><Identifier Source="ORCID">0000-0003-1355-8401</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, CA, 94158, USA. Graeme.davis@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K99 NS100988</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062422</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS097212</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG023501</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG019724</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 NS100988</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG049152</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062588</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM138116</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028044">Phosphate-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C569017">SVIP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.6</RegistryNumber><NameOfSubstance UI="D000074405">Valosin Containing Protein</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C563476">Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049288" MajorTopicYN="N">Muscular Dystrophies, Limb-Girdle</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018979" MajorTopicYN="N">Myositis, Inclusion Body</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010001" MajorTopicYN="N">Osteitis Deformans</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028044" MajorTopicYN="N">Phosphate-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074405" MajorTopicYN="N">Valosin Containing Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33479240</ArticleId><ArticleId IdType="pmc">PMC7820495</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-20796-8</ArticleId><ArticleId IdType="pii">10.1038/s41467-020-20796-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baek GH, et al. Cdc48: a swiss army knife of cell biology. J. Amino Acids. 2013;2013:183421. doi: 10.1155/2013/183421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/183421</ArticleId><ArticleId IdType="pmc">PMC3791797</ArticleId><ArticleId IdType="pubmed">24167726</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts GDJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004;36:377&#x2013;381. doi: 10.1038/ng1332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1332</ArticleId><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y, et al. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2012;33:2231.e1&#x2013;2231.e6. doi: 10.1016/j.neurobiolaging.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.04.005</ArticleId><ArticleId IdType="pmc">PMC3391327</ArticleId><ArticleId IdType="pubmed">22572540</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, W. K. &amp; Xia, D. Mutations in the human AAA+ chaperone p97 and related diseases. Front. Mol. Biosci.3, 79 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131264</ArticleId><ArticleId IdType="pubmed">27990419</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemen CS, et al. Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases. Brain. 2010;133:2920&#x2013;2941. doi: 10.1093/brain/awq222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq222</ArticleId><ArticleId IdType="pubmed">20833645</ArticleId></ArticleIdList></Reference><Reference><Citation>Liewluck, T. et al. A novel VCP mutation underlies scapuloperoneal muscular dystrophy and dropped head syndrome featuring lobulated fibers. Muscle Nerve10.1002/mus.24290 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24838343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim NC, et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 2013;78:65&#x2013;80. doi: 10.1016/j.neuron.2013.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.029</ArticleId><ArticleId IdType="pmc">PMC3683300</ArticleId><ArticleId IdType="pubmed">23498974</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina S, et al. Phenotypic variability in three families with valosin-containing protein mutation. Eur. J. Neurol. 2013;20:251&#x2013;258. doi: 10.1111/j.1468-1331.2012.03831.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2012.03831.x</ArticleId><ArticleId IdType="pmc">PMC3734548</ArticleId><ArticleId IdType="pubmed">22900631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimonis VE, et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am. J. Med. Genet. A. 2008;146A:745&#x2013;757. doi: 10.1002/ajmg.a.31862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.31862</ArticleId><ArticleId IdType="pmc">PMC2467391</ArticleId><ArticleId IdType="pubmed">18260132</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl CC, Pestronk A, Kimonis VE. Valosin-containing protein disease: inclusion body myopathy with Paget&#x2019;s disease of the bone and fronto-temporal dementia. Neuromuscul. Disord. 2009;19:308&#x2013;315. doi: 10.1016/j.nmd.2009.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2009.01.009</ArticleId><ArticleId IdType="pmc">PMC2859037</ArticleId><ArticleId IdType="pubmed">19380227</ArticleId></ArticleIdList></Reference><Reference><Citation>Moir D, Stewart SE, Osmond BC, Botstein D. Cold-sensitive cell-division-cycle mutants of yeast: isolation, properties, and pseudoreversion studies. Genetics. 1982;100:547&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1201831</ArticleId><ArticleId IdType="pubmed">6749598</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon A, McKearin D. Identification of TER94, an AAA ATPase protein, as a bam-dependent component of the Drosophila fusome. Mol. Biol. Cell. 1999;10:3825&#x2013;3834. doi: 10.1091/mbc.10.11.3825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.10.11.3825</ArticleId><ArticleId IdType="pmc">PMC25682</ArticleId><ArticleId IdType="pubmed">10564274</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y-C, et al. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model. PLoS Genet. 2011;7:e1001288. doi: 10.1371/journal.pgen.1001288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1001288</ArticleId><ArticleId IdType="pmc">PMC3033380</ArticleId><ArticleId IdType="pubmed">21304887</ArticleId></ArticleIdList></Reference><Reference><Citation>Tresse E, et al. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy. 2010;6:217&#x2013;227. doi: 10.4161/auto.6.2.11014.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.2.11014</ArticleId><ArticleId IdType="pmc">PMC2929010</ArticleId><ArticleId IdType="pubmed">20104022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju J-S, et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009;187:875&#x2013;888. doi: 10.1083/jcb.200908115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908115</ArticleId><ArticleId IdType="pmc">PMC2806317</ArticleId><ArticleId IdType="pubmed">20008565</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, A. E., Shu, H., Hauswirth, A. G., Tong, A. &amp; Davis, G. W. VCP-dependent muscle degeneration is linked to defects in a dynamic tubular lysosomal network in vivo. elife 4, e07366 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4574298</ArticleId><ArticleId IdType="pubmed">26167652</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget&#x2019;s disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J. Mol. Neurosci. 2011;45:522&#x2013;531. doi: 10.1007/s12031-011-9627-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9627-y</ArticleId><ArticleId IdType="pubmed">21892620</ArticleId></ArticleIdList></Reference><Reference><Citation>Halawani D, Latterich M. p97: The cell&#x2019;s molecular purgatory? Mol. Cell. 2006;22:713&#x2013;717. doi: 10.1016/j.molcel.2006.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2006.06.003</ArticleId><ArticleId IdType="pubmed">16793541</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H, Bug M, Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 2012;14:117&#x2013;123. doi: 10.1038/ncb2407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2407</ArticleId><ArticleId IdType="pubmed">22298039</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich E, Kerem A, Fr&#xf6;hlich K-U, Diamant N, Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 2002;22:626&#x2013;634. doi: 10.1128/MCB.22.2.626-634.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.2.626-634.2002</ArticleId><ArticleId IdType="pmc">PMC139744</ArticleId><ArticleId IdType="pubmed">11756557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bento AC, et al. UBXD1 is a mitochondrial recruitment factor for p97/VCP and promotes mitophagy. Sci. Rep. 2018;8:12415. doi: 10.1038/s41598-018-30963-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30963-z</ArticleId><ArticleId IdType="pmc">PMC6098094</ArticleId><ArticleId IdType="pubmed">30120381</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, T., Mishra, P., Hay, B. A., Chan, D. &amp; Guo, M. Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants. elife6, e17834 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360448</ArticleId><ArticleId IdType="pubmed">28322724</ArticleId></ArticleIdList></Reference><Reference><Citation>Custer SK, Neumann M, Lu H, Wright AC, Taylor JP. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum. Mol. Genet. 2010;19:1741&#x2013;1755. doi: 10.1093/hmg/ddq050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq050</ArticleId><ArticleId IdType="pubmed">20147319</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballar P, et al. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation. J. Biol. Chem. 2007;282:33908&#x2013;33914. doi: 10.1074/jbc.M704446200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M704446200</ArticleId><ArticleId IdType="pubmed">17872946</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagahama M, et al. SVIP is a novel VCP/p97-interacting protein whose expression causes cell vacuolation. Mol. Biol. Cell. 2003;14:262&#x2013;273. doi: 10.1091/mbc.02-07-0115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.02-07-0115</ArticleId><ArticleId IdType="pmc">PMC140243</ArticleId><ArticleId IdType="pubmed">12529442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. SVIP induces localization of p97/VCP to the plasma and lysosomal membranes and regulates autophagy. PLoS ONE. 2011;6:e24478. doi: 10.1371/journal.pone.0024478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0024478</ArticleId><ArticleId IdType="pmc">PMC3164199</ArticleId><ArticleId IdType="pubmed">21909394</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann P, Schindelin H. The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97. J. Biol. Chem. 2011;286:38679&#x2013;38690. doi: 10.1074/jbc.M111.274506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.274506</ArticleId><ArticleId IdType="pmc">PMC3207442</ArticleId><ArticleId IdType="pubmed">21914798</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney ST, Davis GW. Unrestricted synaptic growth in spinster-a late endosomal protein implicated in TGF-beta-mediated synaptic growth regulation. Neuron. 2002;36:403&#x2013;416. doi: 10.1016/S0896-6273(02)01014-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)01014-0</ArticleId><ArticleId IdType="pubmed">12408844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvezin C, Ayala C, Braden CR, Kim J, Neufeld TP. Assays to monitor autophagy in Drosophila. Methods. 2014;68:134&#x2013;139. doi: 10.1016/j.ymeth.2014.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2014.03.014</ArticleId><ArticleId IdType="pmc">PMC4048785</ArticleId><ArticleId IdType="pubmed">24667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouillet A, et al. ER stress inhibits neuronal death by promoting autophagy. Autophagy. 2012;8:915&#x2013;926. doi: 10.4161/auto.19716.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.19716</ArticleId><ArticleId IdType="pmc">PMC3427257</ArticleId><ArticleId IdType="pubmed">22660271</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow CY, Wolfner MF, Clark AG. Using natural variation in Drosophila to discover previously unknown endoplasmic reticulum stress genes. Proc. Natl Acad. Sci. USA. 2013;110:9013&#x2013;9018. doi: 10.1073/pnas.1307125110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1307125110</ArticleId><ArticleId IdType="pmc">PMC3670321</ArticleId><ArticleId IdType="pubmed">23667151</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzaq A, et al. Amphiphysin is necessary for organization of the excitation-contraction coupling machinery of muscles, but not for synaptic vesicle endocytosis in Drosophila. Genes Dev. 2001;15:2967&#x2013;2979. doi: 10.1101/gad.207801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.207801</ArticleId><ArticleId IdType="pmc">PMC312829</ArticleId><ArticleId IdType="pubmed">11711432</ArticleId></ArticleIdList></Reference><Reference><Citation>Pielage J, Fetter RD, Davis GW. Presynaptic Spectrin is essential for synapse stabilization. Curr. Biol. 2005;15:918&#x2013;928. doi: 10.1016/j.cub.2005.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2005.04.030</ArticleId><ArticleId IdType="pubmed">15916948</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton BA, Fetter RD, Davis GW. Dynactin is necessary for synapse stabilization. Neuron. 2002;34:729&#x2013;741. doi: 10.1016/S0896-6273(02)00721-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00721-3</ArticleId><ArticleId IdType="pubmed">12062020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer&#x2019;s disease. J. Neurosci. 1996;16:186&#x2013;199. doi: 10.1523/JNEUROSCI.16-01-00186.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-01-00186.1996</ArticleId><ArticleId IdType="pmc">PMC6578706</ArticleId><ArticleId IdType="pubmed">8613784</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin HZ, et al. Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice. Cell Death Dis. 2012;3:e374&#x2013;e374. doi: 10.1038/cddis.2012.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2012.115</ArticleId><ArticleId IdType="pmc">PMC3434652</ArticleId><ArticleId IdType="pubmed">22898872</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr BO, Borgen MA, Caruccio PM, Murphey RK. Netrin and Frazzled regulate presynaptic gap junctions at a Drosophila giant synapse. J. Neurosci. 2014;34:5416&#x2013;5430. doi: 10.1523/JNEUROSCI.3183-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3183-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608228</ArticleId><ArticleId IdType="pubmed">24741033</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen MJ, Godenschwege TA, Tanouye MA, Phelan P. Making an escape: development and function of the Drosophila giant fibre system. Semin. Cell Dev. Biol. 2006;17:31&#x2013;41. doi: 10.1016/j.semcdb.2005.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2005.11.011</ArticleId><ArticleId IdType="pubmed">16378740</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oosten-Hawle P, Porter RS, Morimoto RI. Regulation of organismal proteostasis by transcellular chaperone signaling. Cell. 2013;153:1366&#x2013;1378. doi: 10.1016/j.cell.2013.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.05.015</ArticleId><ArticleId IdType="pmc">PMC3955170</ArticleId><ArticleId IdType="pubmed">23746847</ArticleId></ArticleIdList></Reference><Reference><Citation>Demontis F, Perrimon N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell. 2010;143:813&#x2013;825. doi: 10.1016/j.cell.2010.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.10.007</ArticleId><ArticleId IdType="pmc">PMC3066043</ArticleId><ArticleId IdType="pubmed">21111239</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando R, Drescher C, Nowotny K, Grune T, Castro JP. Impaired proteostasis during skeletal muscle aging. Free Radic. Biol. Med. 2019;132:58&#x2013;66. doi: 10.1016/j.freeradbiomed.2018.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.08.037</ArticleId><ArticleId IdType="pubmed">30194981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik S, Cuervo AM. Proteostasis and aging. Nat. Med. 2015;21:1406&#x2013;1415. doi: 10.1038/nm.4001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4001</ArticleId><ArticleId IdType="pubmed">26646497</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaips CL, Jayaraj GG, Hartl FU. Pathways of cellular proteostasis in aging and disease. J. Cell Biol. 2018;217:51&#x2013;63. doi: 10.1083/jcb.201709072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201709072</ArticleId><ArticleId IdType="pmc">PMC5748993</ArticleId><ArticleId IdType="pubmed">29127110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443:780&#x2013;786. doi: 10.1038/nature05291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05291</ArticleId><ArticleId IdType="pubmed">17051204</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury JJ, et al. Walking the tightrope: proteostasis and neurodegenerative disease. J. Neurochem. 2016;137:489&#x2013;505. doi: 10.1111/jnc.13575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13575</ArticleId><ArticleId IdType="pubmed">26872075</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein DC, Mari&#xf1;o G, Kroemer G. Autophagy and aging. Cell. 2011;146:682&#x2013;695. doi: 10.1016/j.cell.2011.07.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.07.030</ArticleId><ArticleId IdType="pubmed">21884931</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu H, O&#x2019;Dowd DK. Cholinergic synaptic transmission in adult Drosophila Kenyon cells in situ. J. Neurosci. 2006;26:265&#x2013;272. doi: 10.1523/JNEUROSCI.4109-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4109-05.2006</ArticleId><ArticleId IdType="pmc">PMC6674319</ArticleId><ArticleId IdType="pubmed">16399696</ArticleId></ArticleIdList></Reference><Reference><Citation>Budnik V, et al. Regulation of synapse structure and function by the Drosophila tumor suppressor gene dlg. Neuron. 1996;17:627&#x2013;640. doi: 10.1016/S0896-6273(00)80196-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80196-8</ArticleId><ArticleId IdType="pmc">PMC4661176</ArticleId><ArticleId IdType="pubmed">8893021</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SK, et al. OASIS 2: online application for survival analysis 2 with features for the analysis of maximal lifespan and healthspan in aging research. Oncotarget. 2016;7:56147&#x2013;56152. doi: 10.18632/oncotarget.11269.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.11269</ArticleId><ArticleId IdType="pmc">PMC5302902</ArticleId><ArticleId IdType="pubmed">27528229</ArticleId></ArticleIdList></Reference><Reference><Citation>Geier EG, et al. Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia. Acta Neuropathol. 2018;137:71&#x2013;88. doi: 10.1007/s00401-018-1925-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1925-9</ArticleId><ArticleId IdType="pmc">PMC6371791</ArticleId><ArticleId IdType="pubmed">30382371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>